Kremer, J.M., Bloom, B.J., Breedveld, F.C., Coombs, J.H., Fletcher, M.P., et al. (2009) The Safety and Efficacy of a JAK Inhibitor in Patients with Active Rheumatoid Arthritis: Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 versus Placebo. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 60, 1895-1905.
https://doi.org/10.1002/art.24567

has been cited by the following article:

• TITLE: Chronic Immune Thrombocytopenic Purpura in a Young Female with Rheumatoid Arthritis (Unusual Course)

  AUTHORS: Sara Elhadari, Asif Hashmi, Hani Hussein

  KEYWORDS: ITP, Immune Thrombocytopenic Purpura, Drug-Induced Thrombocytopenia, DITP, Pregnancy, Rheumatoid Arthritis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.11, November 15, 2018

  ABSTRACT: We present a case of a 29-year-old female from Sudan, who was diagnosed with rheumatoid arthritis (RA) in 2005 and with immune thrombocytopenic purpura (ITP) in 2009. The ITP immediately followed using, for four weeks, a combination of medications that included rifampicin. The platelets count continued to be low thereafter. During the year following her diagnosis with ITP, she reported gradual improvement in her joints symptoms, which continued during her pregnancy in 2011. Following puerperium, her chronic ITP resolved completely; however, her joint disease flared up few months later. To our knowledge, there are no reported cases of chronic ITP, which were drug induced at first in a patient of RA except with gold therapy. Similarly, there are no reports on cases that recovered from chronic ITP after delivery. Finally, this case highlights the impact different coexisting autoimmune diseases may have on each other regarding course and prognosis.